Commerce Bank Regeneron Pharmaceuticals, Inc. Transaction History

Commerce Bank

$16.1 Billion
Q3 2024

A detailed history of Commerce Bank transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Commerce Bank holds 6,715 shares of REGN stock, worth $5.25 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

6,715

Previous 6,780 0.96%

Holding current value

$5.25 Million

Previous $7.13 Million 0.93%

% of portfolio

0.04%

Previous 0.05%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$1024.09 - $1201.76 $66,565 - $78,114	-65 Reduced 0.96%	6,715 $7.06 Million
Q2 2024 Aug 12, 2024	BUY	$883.2 - $1071.19 $471,628 - $572,015	534 Added 8.55%	6,780 $7.13 Million
Q1 2024 May 03, 2024	BUY	$902.69 - $993.35 $26,178 - $28,807	29 Added 0.47%	6,246 $6.01 Million
Q4 2023 Feb 09, 2024	BUY	$775.18 - $881.7 $199,221 - $226,596	257 Added 4.31%	6,217 $5.46 Million
Q3 2023 Nov 13, 2023	SELL	$692.45 - $844.37 $6,232 - $7,599	-9 Reduced 0.15%	5,960 $4.9 Million
Q2 2023 Aug 08, 2023	BUY	$700.03 - $830.35 $65,802 - $78,052	94 Added 1.6%	5,969 $4.29 Million
Q1 2023 May 04, 2023	BUY	$680.49 - $826.97 $34,704 - $42,175	51 Added 0.88%	5,875 $4.83 Million
Q4 2022 Feb 10, 2023	SELL	$705.89 - $766.39 $25,412 - $27,590	-36 Reduced 0.61%	5,824 $4.2 Million
Q3 2022 Nov 04, 2022	SELL	$573.97 - $724.32 $207,203 - $261,479	-361 Reduced 5.8%	5,860 $4.04 Million
Q2 2022 Aug 12, 2022	SELL	$548.35 - $738.84 $9,321 - $12,560	-17 Reduced 0.27%	6,221 $3.68 Million
Q1 2022 May 09, 2022	SELL	$595.12 - $698.43 $558,222 - $655,127	-938 Reduced 13.07%	6,238 $4.36 Million
Q4 2021 Feb 14, 2022	SELL	$543.48 - $670.97 $2.52 Million - $3.11 Million	-4,637 Reduced 39.25%	7,176 $4.53 Million
Q3 2021 Nov 09, 2021	BUY	$574.03 - $680.96 $1.72 Million - $2.04 Million	2,996 Added 33.98%	11,813 $7.15 Million
Q2 2021 Aug 09, 2021	SELL	$472.8 - $558.54 $216,069 - $255,252	-457 Reduced 4.93%	8,817 $4.92 Million
Q1 2021 May 05, 2021	SELL	$446.73 - $548.2 $893 - $1,096	-2 Reduced 0.02%	9,274 $4.39 Million
Q4 2020 Feb 09, 2021	BUY	$478.3 - $607.98 $55,004 - $69,917	115 Added 1.26%	9,276 $4.48 Million
Q3 2020 Nov 06, 2020	SELL	$544.75 - $658.21 $633,544 - $765,498	-1,163 Reduced 11.27%	9,161 $5.13 Million
Q2 2020 Aug 07, 2020	BUY	$493.32 - $643.92 $1.25 Million - $1.63 Million	2,534 Added 32.53%	10,324 $6.44 Million
Q1 2020 May 08, 2020	BUY	$336.18 - $494.43 $233,645 - $343,628	695 Added 9.8%	7,790 $3.8 Million
Q4 2019 Feb 14, 2020	BUY	$274.13 - $376.51 $81,690 - $112,199	298 Added 4.38%	7,095 $2.66 Million
Q3 2019 Nov 12, 2019	BUY	$273.46 - $318.39 $37,464 - $43,619	137 Added 2.06%	6,797 $1.89 Million
Q2 2019 Aug 07, 2019	SELL	$299.6 - $414.82 $96,171 - $133,157	-321 Reduced 4.6%	6,660 $2.09 Million
Q1 2019 May 08, 2019	SELL	$372.08 - $439.57 $309,942 - $366,161	-833 Reduced 10.66%	6,981 $2.87 Million
Q4 2018 Feb 11, 2019	BUY	$335.82 - $403.04 $202,163 - $242,630	602 Added 8.35%	7,814 $2.92 Million
Q3 2018 Nov 02, 2018	BUY	$351.14 - $408.51 $37,571 - $43,710	107 Added 1.51%	7,212 $2.91 Million
Q2 2018 Aug 08, 2018	BUY	$284.6 - $344.99 $19,068 - $23,114	67 Added 0.95%	7,105 $2.45 Million
Q1 2018 May 03, 2018	BUY	$315.82 - $393.78 $320,241 - $399,292	1,014 Added 16.83%	7,038 $2.42 Million
Q4 2017 Feb 12, 2018	BUY	$358.63 - $469.95 $17,572 - $23,027	49 Added 0.82%	6,024 $2.27 Million
Q3 2017 Nov 07, 2017	SELL	$431.38 - $504.0 $6,470 - $7,560	-15 Reduced 0.25%	5,975 $2.93 Million
Q3 2017 Nov 07, 2017	BUY	$431.38 - $504.0 $2.58 Million - $3.02 Million	5,990	5,990 $2.68 Million

Others Institutions Holding REGN

# of Institutions

1,524

Shares Held

84M

Call Options Held

1.14M

Put Options Held

1.48M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $83.9B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Commerce Bank, based on Form 13F filings with the SEC.

News

Stay updated on Commerce Bank with notifications on news.

Account